| Bioactivity | Bucolome is a CYP2C9 inhibitor, used as an uricosuric agent or anti-inflammatory agent. |
| Invitro | Bucolome is a potent mixed-type inhibitor for (S)-warfarin 7-hydroxylation, with Ki of 8.2 and 20.2 μM, respectively[1]. |
| Name | Bucolome |
| CAS | 841-73-6 |
| Formula | C14H22N2O3 |
| Molar Mass | 266.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Takahashi H, et al. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Drug Metab Dispos. 1999 Oct;27(10):1179-86. |